| Literature DB >> 29138414 |
Adriana Mika1,2, Zbigniew Kaczynski3, Piotr Stepnowski4, Maciej Kaczor5, Monika Proczko-Stepaniak5, Lukasz Kaska5, Tomasz Sledzinski6.
Abstract
Routine laboratory lipid assays include simple measurements of total cholesterol, triacylglycerols and HDL. However, lipids are a large group of compounds involved in many metabolic pathways, and their alterations may have serious health consequences. In this study, we used 1H NMR to analyze lipids extracted from sera of 16 obese patients prior to and after bariatric surgeries. We observed a post-surgery decrease in serum concentrations of lipids from various groups. The hereby presented findings imply that 1H NMR is suitable for rapid, simple and non-invasive detection of lipids from 30 structural groups, among them triacylglycerols, phosphatidylcholine, phosphatidylethanolamine, sphingomyelin, total phospholipids, total, free and esterified cholesterol, total and unsaturated fatty acids. NMR-based analysis of serum lipids may contribute to a substantial increase in the number of routinely determined markers from this group; therefore, it may find application in clinical assessment of obese subjects prior to and after bariatric surgeries, as well as in the examination of patients with other metabolic diseases.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29138414 PMCID: PMC5686116 DOI: 10.1038/s41598-017-15346-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Use of lipidomics in the management of various diseases.
Figure 2Upper panel: A representative 1H NMR spectrum of serum from obese patient, with resonance signals assigned to respective groups of lipids; bottom panel: HSQC spectrum. All detected structural groups are listed in Table 1.
Mean changes (Λ) in lipid classes level 6 months after bariatric surgery.
| Resonance No | 1H NMR signal | Chemical shift (ppm) | Λ (%) | Mean Λ (%) of common signals of lipids |
|---|---|---|---|---|
|
| –C18 | 0.55 | −82.5 | |
|
| –C18 | 0.70 | −44.2 | TOTAL CHOLESTEROL −48.4 |
|
| –C26 | 0.86 | −52.7 | |
|
| –C21 | 0.93 | −43.9 | FREE CHOLESTEROL −44.2 |
|
| –C19 | 1,02 | −44.7 | |
|
| –C19 | 1.04 | −44.1 | ESTERIFIED CHOLESTEROL −43.2 |
|
| –3C | 4.60 | −42.4 | |
|
| –C | 0.89 | −51.8 | TOTAL FATTY ACIDS −49.4 |
|
| –(C | 1.27 | −50.4 | |
|
| –CO-CH2C | 1.61 | −47.0 | |
|
| –CO-C | 2.3 | −48.3 | |
|
| =CHC | 1.32 | −49.6 | UNSATURATED FATTY ACIDS −49.7 |
|
| – | 5.37 | −49.8 | |
|
| –C | 2.03 | −48.6 | |
|
| –C | 2.08 | −48.8 | |
|
| –CH | 2.78 | −47.5 | |
|
| –CH | 2.84 | −53.3 | |
|
| –C | 3.26 | −44.8 | PHOSPHATIDYLETHANOLAMINE −42.1 |
|
| –>C2 | 3.92 | −39.4 | |
|
| –N+ (C | 3.22 | −43.8 | PHOSPHATIDYLCHOLINE −41.1 |
|
| –C | 3.68 | −38.4 | |
|
| >C3 | 4.01 | −39.9 | PHOSPHOLIPIDS −41.6 |
|
| –C1 | 4.43 | −39.9 | |
|
| –C2 | 5.24 | −44.9 | |
|
| >C1 | 4.33 | −56.2 | TRIACYLGLYCEROLS −57.2 |
|
| –>C2 | 5.28 | −58.3 | |
|
| –N + (C | 3.21 | −47.2 | SPHINGOMYELINS −44.7 |
|
| –C | 3.62 | −43.3 | |
|
| –C | 4.25 | −43.6 | |
|
| >C1 | 4.16 | −51.5 |
Figure 3Associations between C18H3 and C26H3 1H NMR signals for total cholesterol (A), C18H3 1H NMR signal for total cholesterol and serum cholesterol concentration determined routinely at a clinical laboratory (B), C26H3 1H NMR signal for total cholesterol and serum cholesterol concentration determined routinely at a clinical laboratory (C) in the study subjects.
Figure 4Associations between C3H2 and C1H2 1H NMR signals for triacylglycerol (A), C3H2 and C1H2 1H NMR signals for triacylglycerol (B), C1H2 and C2H1H NMR signals for triacylglycerol (C), C3H2 1H NMR signal for triacylglycerol and serum triacylglycerol concentration determined routinely at a clinical laboratory (D), C1H2 1H NMR signal for triacylglycerol and serum triacylglycerol concentration determined routinely at a clinical laboratory (E), C2H1H NMR signal for triacylglycerol and serum triacylglycerol concentration determined routinely at a clinical laboratory (F) in the study subjects.
Biochemical and anthropometric characteristics of the study subjects.
| Before BS (Mean ± SEM) | 6 months after BS (Mean ± SEM) | |
|---|---|---|
| Age (years) | 44 ± 3.1 | — |
| BM (kg) | 119 ± 4.6 | 91 ± 3.6* |
| BMI (kg/m2) | 41 ± 1.1 | 31 ± 1.1* |
| Triglycerides (mg/dL) | 119 ± 22 | 83 ± 11* |
| Total cholesterol (mmol/L) | 190 ± 11 | 179 ± 12* |
| HDL (mmol/L) | 45 ± 2.6 | 52 ± 2.8* |
| LDL (mmol/L) | 122 ± 9.5 | 110 ± 10* |
| Creatinine (mg/dL) | 0.84 ± 0.04 | 0.73 ± 0.03* |
| Insulin (µU/mL) | 17 ± 3.7 | 5.6 ± 0.47* |
| Glucose (mg/dL) | 98 ± 11 | 86 ± 2.1 |
| Albumin (g/L) | 40 ± 0.81 | 39 ± 0.53 |
BM – Body mass
BS - Bariatric surgery
*p < 0.05.
Figure 5A conceptual image presenting the overview of the methodology used in this study. The most important advantage of this approach is significantly increased number of analyzed serum lipid species comparing to standard serum lipid assay in clinical laboratory. The measurement of these lipid species (e.g. phospholipids) is not possible by standard enzymatic assays. Moreover their measurement by our NMR method can be performed in just a few minutes.